Sarah Wellik is an Ophthalmology physician affiliated with University of Miami. OpenAlex indexes 69 publications with 1,940 citations (h-index 20).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
900 NW 17th St
Miami, FL 331361119
Telephone
305-243-6837Registry record last updated 8 Jul 2007.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alcon Vision LLCProgram year20256 payments
- Glaukos CorporationProgram year20251 payment
- Mallinckrodt Hospital Products Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
80.7%Prostaglandin Analog33.3%Latanoprost87%Lumigan8%Travoprost5%Zioptan1%Part D<11 patientsCarbonic Anhydrase Inhibitor21.1%Dorzolamide-Timolol74%Dorzolamide Hcl20%Brinzolamide3%Acetazolamide2%Simbrinza1%Azopt1%Part D<11 patients+ 9 more classes in this area
Cardiovascular
10.3%Beta blocker10.3%Timolol Maleate98%Istalol3%Part D<11 patientsMusculoskeletal
3.6%Nonsteroidal Anti-inflammatory Drug3%Diclofenac Sodium100%Part D≥104 patientsCyclooxygenase Inhibitor0.6%Ketorolac Tromethamine100%Part D≥16 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The Impact of Myopia on Regional Visual Field Loss and Progression in Glaucoma
Translational Vision Science & Technology
2025 - Transformer-Based Deep Learning Prediction of 10-Degree Humphrey Visual Field Tests From 24-Degree Data
Translational Vision Science & Technology
2024 - Outcomes of Glaucoma Reoperations in the Primary Tube Versus Trabeculectomy Study
Ophthalmology Glaucoma
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Myerburg, MD
University of Miami
Thomas Hooton, MD
University of Miami
Harry Flynn, MD
University of Miami
Alan Wein, MD
University of Miami
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”